Market Pulse · Legal, Regulatory & Policy
Regulatory action & investigations
Every S&P 500 company that raised Regulatory action & investigations in its filings, earnings calls, press releases or news coverage over the last 7 days — grouped by the canonical driver, so the same subject lines up across companies whatever each called it.
16 companies · 21 events · 3 positive · 3 negative · 1 mixed · 9 no estimate (counted in companies, so the parts add up)
Companies raising Regulatory action & investigations
- NEE — Dominion Merger Regulatory ReviewImportance 58 · Surprise 42NEXTERA ENERGY INC · News · 2026-11-12Virginia's Consumer Counsel said the merger filing has gaps in data on competitive effects, rate impacts, and consumer safeguards, and asked regulators to examine alleged filing errors and unclear market-impact…
- D — Regulatory RiskImportance 58 · Surprise 42DOMINION ENERGY, INC · News · 2026-11-12Dominion and NextEra’s proposed $67 billion all-stock merger is under regulatory review in Virginia, where the State Corporation Commission is weighing customer protections, reliability, and potential effects on…
- LLY — Regulatory Approval - OrforglipronImportance 53 · Surprise 60ELI LILLY & Co · News · 2026-11-13 · 3 eventsChina's National Medical Products Administration approved Eli Lilly's weight-loss pill orforglipron, marketed as Foundayo. The approval makes it the first oral GLP-1 treatment for obesity available in China and permits…
- PFE — GLP-1 Development Funding DealImportance 53 · Surprise 42PFIZER INC · News · 2026-11-12Blackstone Life Sciences will provide Pfizer up to $1.5 billion through 2028 to fund development of berobenatide, an investigational monthly GLP-1 receptor agonist for chronic weight management. Pfizer will retain full…
- SMCI — DOJ China Smuggling InvestigationImportance 47 · Surprise 60Super Micro Computer, Inc. · News · 2026-11-12Bloomberg reported on November 12 that the U.S. Justice Department was investigating whether entities linked to Alice Huang were involved in efforts to smuggle Super Micro products into China. The inquiry is being led…
- GOOG — South Korea Maps Regulatory RestrictionsImportance 45 · Surprise 42Alphabet Inc. · News · 2026-11-13 · 2 eventsSouth Korean officials said Google deleted location coordinates from Google Maps and Google Earth to comply with national security standards, and Google must also remove Street View photographs of critical places.…
- META — Privacy Regulatory FineImportance 41 · Surprise 60Meta Platforms, Inc. · News · 2026-11-15 · 2 eventsMeta faces a proposed €880 million fine in Italy over alleged misuse of users’ photos and metadata. Italy’s data protection authority alleges that Facebook’s Gallery Suggestions feature accessed and processed images…
- DXCM — Regulatory Approval MilestonesImportance 41 · Surprise 60DEXCOM INC · News · 2026-11-12Health Canada approved Dexcom G7 for use with myLoop, powered by CamAPS FX, in an automated insulin delivery system for pregnant women with type 1 diabetes in Canada. The approval makes this the only AID system in…
- VRTX — Regulatory Approval MilestonesImportance 34 · Surprise 42VERTEX PHARMACEUTICALS INC / MA · News · 2026-11-13 · 2 eventsVertex is awaiting an FDA decision on povetacicept for IgA nephropathy, scheduled for November 30, 2026. The article says approval could expand the company’s commercial portfolio beyond cystic fibrosis but provides no…
- MRK — Regulatory Approval MilestonesImportance 34 · Surprise 42Merck & Co., Inc. · News · 2026-11-13The European Medicines Agency’s CHMP recommended expanding ENFLONSIA (clesrovimab) to prevent RSV lower respiratory tract disease in children up to 24 months old who remain at increased risk of severe disease through…
- ICE — Wind Futures LaunchImportance 30 · Surprise 42Intercontinental Exchange, Inc. · News · 2026-11-14Intercontinental Exchange plans to list 15 cash-settled wind futures tied to ENWEX indices across seven major European wind markets, with launch scheduled for December 14, 2026, subject to regulatory approvals. The…
- HCA — Securities Fraud InvestigationImportance 28 · Surprise 42HCA Healthcare, Inc. · News · 2026-11-12Pomerantz LLP is investigating HCA Healthcare and certain executives over alleged securities fraud or unlawful business practices. The investigation follows HCA’s July 2026 reduction of its full-year profit forecast,…
- USB — Regulatory RiskImportance 26 · Surprise 24US BANCORP DE · News · 2026-11-12U.S. Bancorp is nearing an asset threshold that could move it into Category II supervisory treatment. The report does not identify the threshold amount, when the bank may cross it, or the resulting compliance costs. It…
- CAT — Securities Fraud InvestigationImportance 22 · Surprise 32CATERPILLAR INC · News · 2026-11-13Pomerantz LLP is investigating potential securities fraud claims against Caterpillar on behalf of investors. The investigation follows a 9.25% stock-price drop on October 29, 2026, after Caterpillar reported increased…
- TSLA — Regulatory RiskImportance 17 · Surprise 24Tesla, Inc. · News · 2026-11-13Texas Attorney General-elect Nathan Johnson said a potential Tesla-SpaceX merger would face rigorous state-level oversight. He warned against excessive corporate concentration, creating a potential regulatory hurdle…
- SW — Securities Fraud InvestigationImportance 14 · Surprise 24Smurfit Westrock plc · News · 2026-11-12Pomerantz LLP is investigating potential securities fraud claims against Smurfit Westrock on behalf of investors. The report says the investigation followed the company’s third-quarter 2026 results, which missed…